← Back to headlines
Pfizer's Lyme Vaccine Fails to Meet Efficacy Mark in Study
A recent study has shown that Pfizer's Lyme disease vaccine did not meet its efficacy targets, complicating its path toward regulatory approval.
23 Mar, 18:12 — 23 Mar, 18:12
Sources
Showing 1 of 1 sources
